This chemical is primarily utilized in pharmaceutical research and development, particularly in the synthesis of bioactive compounds. It serves as a key intermediate in the creation of drugs targeting the central nervous system, including potential treatments for neurological disorders such as depression, anxiety, and schizophrenia. Its spirocyclic structure is valuable in designing molecules with enhanced binding affinity and selectivity for specific receptors in the brain. Additionally, it is explored in the development of novel therapeutic agents due to its ability to improve pharmacokinetic properties, such as metabolic stability and bioavailability. Researchers also investigate its potential in creating compounds for pain management and anti-inflammatory applications.